Health EU – Human avatars to prevent and cure diseases

Imagine a revolution in personalized healthcare and disease prevention system in Europe, based on human avatars of healthy individuals and patients for the prevention, interception and cure of disease.

Nothing less is the aim of Health EU (healthy you!), an advanced FET Flagship multidisciplinary research initiative in Europe aiming for a paradigm shift to healthcare and for a future sustainable healthcare system.
Stacks Image 3181
A revolution in human model development is now possible with Health EU by leveraging data from omics analyses, medical and imaging data, environmental and life style big data that are continuously updated by a multitude of biosensors at an unprecedented scale. With these complex data sets, first of their kind(s) human avatars will be built that can be personalised and used to prevent and cure each one’s own disease(s). Health EU will exploit most advanced organ-on-chip, smart nanosensor technologies and nanomedicine techniques to realise, validate and use such personalized human avatars in order to create a revolution in healthcare.

Health EU will boost European innovation and create disruptive advances related to big data analytics, smart micro/nano-systems, nanomedicine and new healthcare services and safer and more effective drugs. It will directly contribute to standards for privacy and security of healthcare data, jointly driven by technology and context. Health EU FET Flagship will provide a truly sustainable approach to healthcare and a better Quality of Life to European citizens.

Our Story

The Health EU FET Flagship is a star Flagship initiative born as a result of merging revolutionary ideas about the future of healthcare and leading European research groups from:
  • the past FET Flagship finalist ‘Guardian Angels for a Smarter Life’, and related most advanced edge of the cloud and Internet of Things sensor and smart system integration technology platforms, centered at IMEC, CEA-LETI and Fraunhofer
  • the Organ-on-Chip Flagship initiative led by the Dutch hDMT (Institute for human Organ and Disease Model Technologies) and its European network
  • a large number of groups and leaders formerly being involved in the Flagship Expression of Interest ‘The Future of Health Care: deep data, smart sensors, virtual patients and the Internet-of-Humans
  • the Nanomedicine European Technology platform
  • key partners from the Flag-Era Convergence project
  • many other European universities, research institutes, hospitals, industries and networks that decided to integrate and support Health EU

Partners

Prof. Alexander M. M. Eggermont — Project Coordinator
Gustave Roussy and Université Paris-Sud, France
Alexander M.M. Eggermont is Professor of Oncology and Director General of the Cancer Institute Gustave Roussy, the premier comprehensive cancer center in Europe. His is the current President of the European Academy of Cancer Sciences (EACS) and the Chair of the Consortium Cancer Core Europe. He is a surgeon and tumor immunologist and a melanoma, sarcoma and drug development specialist, in particular immunotherapy, and a fellow of the NCI-NIH Surgery Branch (Steven Rosenberg). Amongst others he was the PI of TNFalpha, Pegylated Interferon, Ipilimumab and Pembrolizumab trials that all resulted in FDA and EMA approvals. He was Head and Professor of Surgical Oncology at Erasmus University Medical Center 2000-2016, and former president of ECCO and EORTC. Among many academic awards he received Joseph Maisin Chair of the Université de Louvain, Society or Surgical Oncology Clinical Research Award, Dutch Surgical Society Award, ASCO Statemens Award, University of Essen Doctorate Honoris Causa.
Prof. Adrian Ionescu — Project Co-coordinator
École Polytechnique Fédérale de Lausanne (EPFL), Switzerland
Adrian M. Ionescu is a Professor and Director of the Nanoelectronic Devices Laboratory at Ecole Polytechnique Fédérale de Lausanne (EPFL. His group pioneered new concepts in beyond CMOS devices and technologies. He is the recipient of the IBM Faculty Award 2013 and of the André Blondel Medal 2009 of the Society of Electrical and Electronics Engineering, Paris, France. In 2018 he and his co-authors received the IEEE George Smith award for the best paper of IEEE EDL, a leading journal of the Electron Devices Society. He is an IEEE Fellow and a member of the Swiss Academy of Sciences (SATW). In 2016 he was awarded an Advanced ERC Grant to develop energy efficient millivolt transistors and sensors for Internet-of-Things. In 2018, he was appointed as a Chair of the PE7 Committee of the European Research Council (ERC). He was coordinator of many FP6, FP7 and H2020 projects, including the FET Flagship CSA Guardian Angels for a Smarter Life, invited as one of the four finalists in the previous Flagship competition.
Prof. Albert van den Berg — Co-coordinator
University of Twente, Enschede, The Netherlands
Albert van den Berg received his PhD in 1988 at the University of Twente. From 1988-1993 he worked in Neuchatel, Switzerland, at the CSEM and the University (IMT) on miniaturized chemical sensors. In 2000 he was appointed as full professor on Miniaturized Systems for (Bio)Chemical Analysis at the University of Twente. He published over 450 peer-reviewed publications and from his group over 10 spin-off companies started. He received several honors and awards such as Simon Stevin (2002), two ERC Advanced (2008, 2015) and three ERC Proof of Concept (2011, 2013, 2016) grants, Spinoza prize (2009), Distinguished University Professor (Twente, 2010), Consulting Professor at NPU (China), 2017) and was board member of the Royal Dutch Academy of Sciences (KNAW) (2011-2016). In 2017 he became co-PI of the Max Planck - University of Twente Center for Complex Fluid Dynamics, and was appointed (co)director of MESA+ institute for Nanotechnology in 2018.
Prof. Christofer Hierold
Eidgenössische Technische Hochschule Zürich, Switzerland
He has been Professor of Micro and Nanosystems at ETH Zurich, Switzerland, since April 2002. He was Head and Deputy Head of the Department of Mechanical and Process Engineering from 2009 until 2011, and from 2011 until 2014, respectively. He is President of the ETH Zurich Strategy Commission. He held visiting scientist and visiting professor positions at MIT, Cambridge, and at Stanford University, Palo Alto, respectively, both in 2015. He published more than 290 papers in journals and refereed conference proceedings and he is author or co-author of more than 35 granted or published patents. He is designated General Chair of TRANSDUCERS 2019. Since October 2012, he is Editor-in-Chief of the IEEE Journal of Microelectromechanical Systems. He is member and Board member of the Swiss Academy of Engineering Sciences SATW, and IEEE Fellow.
Prof. Enrico Sangiorgi
Consorzio Nazionale Interuniversitario per la Nanoelettronica (IU.NET), Italy
He received the Laurea degree in electrical engineering from the University of Bologna, Italy, in 1979. In 1983, 1984, and 1991, he was a Visiting Scientist at the Center for Integrated Systems, Stanford University, Stanford, California. From 1985 to 2001, he was a consultant at Bell Laboratories, Murray Hill, NJ. Since 2002, he is Professor the University of Bologna, where he has been the Dean of the Faculty of Engineering, Cesena Campus (2008-12) and the Head of the Department of Electrical, Electronic and Information Engineering “Guglielmo Marconi” (2012-15). From 2005 to 2011 he has been the Director of IUNET, a Legal Consortium grouping 11 University Groups and today leader in Europe in the Electron Device modeling field. From 2005 to 2015 he has been a member of the CATRENE Scientific Committee and since 2007 he has been a member of the Managing Committee of AENEAS, the private partner of the Public-Private ECSEL European Technology Platform. Since 2014 he is the Director of the SINANO Institute, grouping 23 European Institutes active in the field of nanoelectronics. He is a Fellow of IEEE and a Member of the Academy of Sciences of Bologna Institute. His research interests, in cooperation with research centers and companies such as Bell Labs., Philips, Infineon, ST Microelectronics, AMAT, IMEC, CEA-LETI, include the physics, characterization, modeling, and fabrication of silicon solid-state devices and integrated circuits.
Prof. Mikael Östling
Kungliga Tekniska Högskolan, Stockholm, Sweden
Mikael Östling is the deputy president of KTH and professor of solid state electronics. He is responsible for strategic collaborations and the research infrastructure. His research interests are semiconductor devices and nanofabrication technology. Östling is the editor-in-chief of the IEEE Journal of Electron Devices Society since 2016. Östling is a Fellow of the IEEE. He has >500 publications. His expertise covers device and sensor manufacturing, emerging devices, heterogeneous integration, embedded electronics.
Dr. Chris Van Hoof
Imec-vzw, Belgium
Chris Van Hoof is Senior Director Connected Health Solutions and responsible for the R&D direction and business strategy of a multi-site R&D team across 3 imec locations (Eindhoven (the Netherlands), Leuven (Belgium) and Gent (Belgium)). He has a track record of 30 years of initiating, executing and leading national and international contract R&D with worldwide customers. Chris is member of the management team of Stichting imec Nederland. He is also full professor at the University of Leuven and an imec Fellow. His innovation covered the domains of advanced imaging, MEMS, ultra-low-power electronics and connected health. He has given published over 700 publications and has given over 100 invited talks. His work has resulted in 5 startup companies, 4 in the health domain. He is a frequent invited or keynote speaker and recognized thought leader in the connected health domain.
Dr. Janny van den Eijinden
Institut for Human organ and Disease Model technologies, The Netherlands
Van den Eijnden-van Raaij is managing director of hDMT. She obtained her PhD as a biochemist at Radboud UMC Nijmegen in 1985. She then became group leader at the Hubrecht Institute Utrecht focusing on stem cells and growth factors in embryonic/ tumour development. In 2003 she became CEO at the Comprehensive Cancer Center South Eindhoven. Under her regime the cancer registry and epidemiological research department developed to the European leader in this field. In 2014 she switched to Organs-on-Chip (OOC) and established hDMT in 2015, a national public-private OOC Consortium of renowned scientists with various backgrounds, who work in academia, companies and UMCs. They share knowledge, expertise and facilities to develop human OOC models, that better recapitulate the human body and will reduce animal experiments. She built a broad (inter)national network on OOC in the H2020 ORCHID project.
Dr. Patrick Boisseau
Commisariat à l’énergie atomique et aux énergies alternatives, Grenoble, France
VP Europe at CEATech Healthcare Institute, based in Grenoble (France). 20+ years of European experience built on collaborative projects, research infrastructures, coordination actions and networks of excellence. General coordinator of the largest EU network on nanobiotechnology Nano2Life, with 450+ participants, 20+ companies coming from 14 EU Member States. Scientific and technical expertise in nanomedicine, drug delivery, medical imaging and innovative medical technologies. Coordinator of the the European Nanomedicine Laboratory, H2020 funded EU infrastructure offering the full physical, chemical, in vitro and in vivo characterisation of nanomaterials intended for medical uses.
Mandates: Chairman of the ETPN, European Technology Platform on Nanomedicine; Chairman of ESTHER, the European Industry Driven Initiative on Emerging and Strategic Technologies for Healthcare, in cooperation with Medtech-Europe.
Prof. Eran Segal
Weizmann Institute of Science, Rehovot, Israel
Professor at the Department of Computer Science and Applied Mathematics at the Weizmann Institute of Science, heading a lab with a multi-disciplinary team of computational biologists and experimental scientists in the area of Computational and Systems biology. His group has extensive experience in machine learning, computational biology, probabilistic models, and analysis of heterogeneous high-throughput genomic data. His research focuses on Nutrition, Genetics, Microbiome, and Gene Regulation and their effect on health and disease. His aim is to develop personalized nutrition and personalized medicine. Prof. Segal published over 130 publications, and received several awards and honors for his work, including the Overton prize, awarded annually by the International Society for Bioinformatics (ICSB) to one scientist for outstanding accomplishments in computational biology, and the Michael Bruno award. He was recently elected as an EMBO member and as a member of the young Israeli academy of science.
Prof. Volkmar Falk
Charité – Universitätsmedizin Berlin, Berlin, Germany
Professor Volkmar Falk, MD, is the Medical Director and Director of the Department of Cardiothoracic and Vascular Surgery at the German Heart Institute Berlin and Charité. He is an expert in minimally invasive and robotic cardiac surgery, which he has helped to co-develop. As an author and co-author, he has been involved in more than 450 scientific publications and is co-editor of the European Heart Journal. Professor Falk has further been involved in several national and European guidelines, which have significantly impacted the standards of care for coronary revascularization, treatment of valve disease and cardiac failure. His current research interests include image-guided therapy to optimize catheter-based valve interventions and the development of new artificial heart systems.
Dr. Peter Ramm
Fraunhofer EMFT, Munich, Germany
Peter Ramm is head of Strategic Projects, staff position to the research institution´s director, responsible for initiation and steering of strategic projects and international research co-operations. He received Masters and PhD degrees from the University of Regensburg and subsequently worked for Siemens in the DRAM facility where he was responsible for the process integration. In 1988 he joined Fraunhofer Munich, focusing for more than 25 years on 3D integration technologies. Peter Ramm is author of over 120 publications and 24 patent families. He received the "Ashman Award 2009" from the International Electronics Packaging Society (IMAPS) "For Pioneering Work on 3D IC Stacking and Integration". Peter Ramm is Senior Member IEEE, IMAPS Fellow and Life Member. He was coordinator / work package leader of European projects since FP4 and has served in the “success story” Large-Scale Integrated Project “e-BRAINS” (FP7-ICT-2009-5) as technical manager.
Dr. Denis Gauvreau
Biocluster Genopôle, Paris, France
Denis GAUVREAU is the Director of International Affairs at Genopole. He is a technology entrepreneur and innovation specialist with over 25 years of achievements in Canada, France and Saudi Arabia. His accomplishments include the creation of the first Canadian genomics company (Algene Biotechnologies) and he also acted as Founder, President-CEO, Executive Chairman, Chairman, Board Director, Counsel, in over 20 early-stage companies. Prior to joining Genopole, he was one of the original members of the group of some 300 Founders of King Abdullah University of Science and Technology (Saudi Arabia) in KAUST’s Department of Economic Development. In his early career, he was Professor at the University of Quebec and at the University of Montreal, where he drove the establishment of a multidisciplinary and inter-institutional research program on the causes of Alzheimer Disease. He obtained his Ph.D. in Pharmacology from the University of Cambridge (UK) and his B.Sc. and M.Sc. in Biochemistry from the University of Montreal.
Dr. Franz Lärmer
Robert Bosch GmbH, Germany
Franz Lärmer joined Bosch in 1990. He developed key technologies and functions for the upcoming field of Micro-Electro-Mechanical Systems (MEMS) with focus on automotive applications. Since 2003, he is Project Director for TOP-level innovation projects in new application fields beyond automotive, including consumer applications and the biomedical area. The Bosch Lab-on-Chip platform which is marketed today by Bosch Healthcare Solutions (BHCS) is among the outcomes of these development efforts. Today he is Senior Chief Expert/Bosch Research Fellow for Microsystems Technologies, Microfluidics and Molecular Diagnostics at the Robert Bosch Research Campus in Renningen, Germany. He was awarded with the prize “European Inventor of the Year 2007 – Category Industry” by the European Commission and the European Patent Office (together with co-inventor Andrea Urban), for the invention, of the “BOSCH-DRIE”-process and received the “2014 IEEE Jun-ichi Nishizawa Medal Award” from IEEE, USA.
Prof. Cisca Wijmenga
University Medical Center Groningen, Groningen, The Netherlands
Cisca Wijmenga is working in the field of gut health using genomics technology to understand health and disease. Her work is focusing on the genetics of celiac disease, the role of the gut microbiome in health and disease and the development of gut-on-chip for more mechanistic research. Her research is interdisciplinary, encompassing the fields of genetics, molecular genetics, epidemiology, immunology, microbiology, computational biology and bioinformatics. She has (co)-authored >550 pubmed-indexed papers, with > 65,000 citations. She was awarded the Spinoza price in 2015 (2,5 million €). She is a member of the Royal Holland Society of Sciences and Humanities (KHMW), the Academia Europaea, and the Dutch Royal Academy of Arts and Sciences (KNAW).
The following partners will work together for a year-long coordination action, preparing the final Flagship Initiative.
Stacks Image 3280
Institut Gustave Roussy
France
Alexander M.M. Eggermont
École polytechnique fédérale de Lausanne
Switzerland
Kamiar Aminian, Jürgen Brugger, Giovanni De Micheli, Bart Deplancke, Christian Enz, Mathias Humbert, Adrian Ionescu, Stéphanie Lacour, Matthias Lütolf, Marco Mattavelli, Philippe Renaud, Ali H. Sayed, Anja Skrivervik, Jean-Philippe Thiran, Olivier Verscheure
Universiteit Twente
The Netherlands
Albert van den Berg, Andries van der Meer
Academisch Ziekenhuis Groningen
The Netherlands
Cisca Wijmenga
Academisch Ziekenhuis Leiden
The Netherlands
Christine Mummery
ENEA
Italy
Girolamo Di Francia, Saverio De Vito
Alleanza Contro il Cancro
Italy
Myriam Alkalay
Ares Trading SA
Switzerland
Charles Massin
Bar-Ilan University
Israel
Aharon Gedanken, Jean-Paul Lellouche
Bayer Aktiengesellschaft
Germany
Lars Küpfer
Bluenove
France
Martin Duval, Jerome Brehin
Centre Hospitalier Universitaire de Grenoble
France
Alexandre Moreau-Gaudry
Centre Hospitalier Universitaire Vaudois
Switzerland
Jocelyne Bloch Pasche, Salah D. Qanadli, Piergiorgio Tozzi
Centre National de la Recherche Scientifique CNRS
France
Dominique Collard, Aurélien Bancaud, Vincent Aimez
Centro de Neurociências e Biologia Celular Associacao
Portugal
Lino Ferreira
Charité - Universitätsmedizin Berlin
Germany
Volkmar Falk, Titus Kuehne, Alexander Meyer
CEA
France
Patrick Boisseau, Thomas Ernst
Consiglio Nazionale delle Ricerche
Italy
Luca Businaro, Pietro Siciliano
IU.NET
Italy
Enrico Sangiorgi, Luca Selmi, Daniele Ielmini, Danilo Demarchi, Luca Benini
CSEM
Switzerland
John Farserotu
Danmarks Tekniske Universitet
Denmark
Jan Madsen
E.P.O.S. Iasis Research and Development Ltd
Cyprus
Andreani D. Odysseos, Loizos Economides
Eberhard Karls Universität Tübingen
Germany
Peter Loskill
Edinethics
UK
Donald Bruce
Eidgenössische Technische Hochschule Zürich
Switzerland
Luca Benini, Joachim Buhmann, Stephen Ferguson, Andreas Hierlemann, Christopher Hierold, Walter Karlen, Bradley Nelson, Lothar Thiele
EMPA
Switzerland
Peter Wick
Elektronikas un Datorzinatnu Instituts
Latvia
Modris Greitans, Kaspars Ozols
Fraunhofer Gesellschaft
Germany
Anja Hennemuth, Christine Kallmayer, Peter Ramm, Andreas Schneider, Madalena Cipriano
Institut Català de Nanociència y Nanotecnología
Spain
José Antonio Garrido
Fundación Cidetec
Spain
Iraida Loinaz
Genopole
France
Denis Gauvreau
Goeteborgs Universitet
Sweden
Prof. Jan Borén, MD, Ph.D, Head of the Institute of Medicine
Hellenic Pasteur Institute
Greece
Rebecca Matsas
Hits gGmbH
Germany
Martin Golebiewski, Wolfgang Müller
Hrvatsko katolicko sveuciliste
Croatia
Anto Čartolovni, Hrvoje Meštrić
IBM Research GmbH
Switzerland
Jonas Weiss
Iigm Foundation
Italy
Ruggero de Maria
Imperial College of Science Technology and Medicine
UK
Marisa Miraldo
Infineon Technologies AG
Germany
Knut Hufeld, Reinhard Pufall
Institut Mines-Télecom
France
Marius Preda
Institut national des sciences appliquées de Lyon
France
Eric McAdams
Institut Polytechnique de Grenoble
France
Francis Balestra
Instituto de Salud Carlos III
Spain
Fernando Martin Sanchez
IMT
Romania
Carmen Moldovan, Raluca Muller
Instytut Biocybernetyki i Inżynierii Biomedycznej
Poland
Adam Liebert
Interuniversitair Micro-Electronica Centrum
Belgium
Chris van Hoof
Istituto Superiore Mario Boella
Italy
Paolo Vergori
Karolinska Institutet
Sweden
Anna Herland
Katholieke Universiteit Leuven
Belgium
Georges Gielen
Kungliga Tekniska Högskolan
Sweden
Mikael Ostling, Matthias Uhlen, Ana Rusu
MPI
Germany
Eberhard Bodenschatz, Detlef Lohse, Stuart Parkin
National Center for Scientific Research "Demokritos"
Greece
Athanasios Dimoulas
National Technical University Of Athens - Ntua
Greece
Ioanna Zergioti, Apostolos Klinakis, Dimitris Tsoukalas, Yannis Raptis
NMI
Germany
Udo Kraushaar
Niped Research Foundation
The Netherlands
Coenraad van Kalken
Norges Teknisk-Naturvitenskapelige Universitet Ntnu
Norway
Frank Lindseth
Otto von Guericke Universität Magdeburg
Germany
Steffen Oeltze-Jafra, Hans-Jochen Heinze, Hermann Hinrichs, Oliver Speck, Emrah Düzel
Philips Electronics Nederland B.V.
The Netherlands
Wim Crooijmans
Queen Mary University of London
UK
Anthony Mathur, Sheik Dowlut
RWTH
Germany
Max Lemme
Rijksuniversiteit Groningen
The Netherlands
Reinoud Gosens; Loes Kistemaker
Robert Bosch GmbH
Germany
Franz Lärmer
Roland Berger GmbH
Germany
Steffen Gackstatter
Sabanci Universitesi
Turkey
Gullu Kiziltas Sendur, Gozde Ince
SCIPROM Sàrl
Switzerland
Kirsten Leufgen, Peter Ulrich
SIB Institut Suisse de Bioinformatique
Switzerland
Jerome Dauvillier
SINTEF AS
Norway
Thomas Langø
Slovenskà technickà univerzita v Bratislave
Slovakia
Daniel Donoval
Sorbonne Université
France
Dr Isabella Annesi-Maesano
Stichting Imec Nederland
The Netherlands
Sywert Brongersma
hDMT
The Netherlands
Albert van den Berg, Janny van den Eijnden, Christine Mummery
Stichting Katholieke Universiteit
The Netherlands
Bas Bloem
STMicroelectronics Srl
Italy
Benedetto Vigna, Andrea Di Matteo, Paolo Ferrari, Ernesto Lasalandra
Tallinna Tehnikaulikool
Estonia
Mart Min
Technische Universität Graz
Austria
Torsten Mayr
Technische Universität München
Germany
Sandra Hirche, Daniel Cremers, Nassir Navab, Bjoern Menze
Technische Universität Wien
Austria
Clemens Heitzinger, Peter Ertl, Mario Rothbauer
Technische Universität Berlin
Germany
Roland Lauster
Technische Universiteit Delft
The Netherlands
Pasqualina M. Sarro, Wouter Serdijn
Technische Universiteit Eindhoven
The Netherlands
Jaap den Toonder, Prof
Teknologian Tutkimuskeskus Vtt Oy
Finland
Ari Alastalo, Veikko Ikonen, Eija Kaasinen
Tel Aviv University
Israel
Dan Peer
University of Cambridge
United Kingdom
Daniel Popa, Flurin Udrea
The University of Auckland
New Zealand
Peter Hunter, Pau Medrano-Gracia, David Nickerson
TTY-säätiö
Finland
Mari Pekkanen-Mattila
Universidad de Zaragoza
Spain
Ignacio Ochoa, Manuel Doblaré; Luis Fernandez
Universita Campus Bio Medico di Roma
Italy
Marco Santonico, Giorgio Pennazza
Universita degli Studi di Cagliari
Italy
Luigi Raffo
Universita degli Studi di Roma Torvergata
Italy
Eugenio Martinelli; Arianna Mencattini
Università degli Studi di Milano-Bicocca
Italy
Marco Antoniotti
Universität Bern
Switzerland
Stephen Leib, Alban Ramette, Denis Grandgirard, Thomas Geiser, Olivier Guenat
Universitaet Leipzig
Germany
Thomas Neumuth
Universitaetsklinikum Aachen
Germany
Fabian Kiessling
Universitat des Saarlandes
Germany
Frank Lammert, Norbert Graf
Universitat Zurich
Switzerland
Giacomo Indiveri
Universitatea Politehnica Din Bucuresti
Romania
Gheorghe Brezeanu, Gheorghe Militaru, George Stanciu
Universitätsklinikum Jena
Germany
Alexander Mosig
Université Catholique de Louvain
Belgium
Denis Fladre, Jean-Pierre Raskin
Université de Lausanne
Switzerland
Ioannis Xenarios
Université du Luxembourg
Luxemburg
Jens Schwamborn, Paul Wilmes
Université Lyon 1 Claude Bernard
France
Abdelhamid Errachid El Salhi, Michel Ovize
Universite Paris-Sud
France
Patrick Couvreur, Elie Lefeuvre
Universiteit Maastricht
The Netherlands
Prof. dr. Pamela Habibović
Universitetet i Oslo
Norway
Stefan Krauss
University College Cork - National University of Ireland
Ireland
Paul Galvin, David Wilson
University of Brighton
United Kingdom
Matteo Santin
University of Surrey
United Kingdom
Christian Heiss, Helen Griffiths, A. Gawer
Uppsala Universitet
Sweden
Susan Peacock
VRVis
Austria
Katja Bühler
Weizmann Institute of Science
Israel
Eran Segal
Over 100 partners from more than 20 EU countries already confirmed their interest in participating in the final Health EU Flagship Initiative.
The Health EU Stakeholder Forum will play a crucial role in shaping our Flagship vision and its implementation by considering the interactive involvement of big industries, SMEs, startups, patient organizations, regulatory bodies, etc.

The Chairs of the Health-EU Stakeholder Forum are Prof. Christofer Hierold (ETHZ) and Dr. Franz Lärmer (VP Corporate Research and Advanced Engineering - Robert Bosch GmbH, Germany).
Stacks Image 3278
Name of the organisationPerson of contactCountry
3D PLUS SASPascal CoudercFrance
AbbVieThomas JahnGermany
AlfaBetaNetLucio AnnunziatoItaly
AlveoliX AGOlivier Guenat, Nina Hobi, Janick StuckiSwitzerland
AMOMax LemmeGermany
Axe PIAxel Gerhardt
BarmerChristoph StraubGermany
Bayer AGLars KüpferGermany
Bioanalytic MünsterKlaus-Michael WeltringGermany
Biocam Scarl Lucio AnnunziatoItaly
BiovistaAndreas Persidis, Eftychia LekkaGreece
Bosch BKKFranz LaermerGermany
Bracco Imaging s.p.a.Fulvio UggeriItaly
CEDEO SASLeonardo Chiariglione Italy
Centre for Process InnovationCharanjeet SinghUnited Kingdom
CIFARAlan BernsteinCanada
Copenhagen Center for Health Technology (cachet) Jakob E. Bardram, Professor and DirectorDenmark
Corti Michael R. Boesen, PhD, Co-founder and VP Special ProjectsDenmark
CPH Health CHCHenning LangbergDenmark
Cyprus Chamber of Commerce and IndustryLeonidas PaschalidesCyprus
Cyprus Ministry of HealthChristina YiannakiCyprus
DDS DiagnosticDana StanRomania
Diavita LtdDimiter DimitrovBulgaria
Dr. SchärOmbretta PolenghiItaly
Dutch Heart FoundationRebecca Abma-SchoutenThe Netherlands
Edinethics LtdDonald BruceUnited Kingdom
EGANCees Smit, Cor OosterwijkThe Netherlands
EIT-HealthJan-Philipp BeckGermany
Eriksholm Research Center (part of Oticon)Uwe Hermann, DirectorDenmark
European Federation of Neurological Associations (EFNA)Cathalijne van DoorneBelgium
European Federation of Pharmaceutical Industries and Associations (EFPIA)Magda ChlebusBelgium
European Lung Foundation (ELF)Emma Thompson, Isabel SairavaUnited Kingdom
European Society for Biomaterials ESBPamela HabibovicFrance
F.R.S.-FNRS Fonds de la Recherche ScientifiqueVéronique HalloinBelgium
Fonds de recherche du QuébecRémi QuirionCanada
Genomics CanadaMarc LepageCanada
GenomSys SAClaudio AlbertiSwitzerland
GlaxoSmithKlineAnthony BahinskiUSA
greenTEG AGWulf GlatzSwitzerland
Génome QuébecDaniel CoderreCanada
Hauptverband der österreichischen SozialversicherungsträgerAlexander BiachAustria
Health Insurance OrganisationAthos TsinontidesCyprus
Helmholtz Inst for Pharma scienceClaus-Michael LehrGermany
InnovAALPietro SicilianoItaly
INRA - Human Nutrition UnitSergio Polakof, Estelle Pujos-Guillot France
InSphero AGOlivier Frey, Jan LichtenbergSwitzerland
Institute for Clinical Pharmacology (IKP)Matthias SchwabGermany
Intelligent Voice LtdFranceGérard Chollet
IST AGMirko LehmannSwitzerland
Istituto Superiore di SanitàGiovanna SchiavoniItaly
JanssenRachel AdamsUnited Kingdom
liferesult srlMassimo PistoiaItaly
LioniX International BVHenk LeeuwisThe Netherlands
LundbeckKenneth ThistrupDenmark
MaxWell BiosystemsUrs Frey, Michele FiscellaSwitzerland
Medicines Evaluation Board (the Netherlands)Jan Willem van der LaanThe Netherlands
MedTronicIves BayonFrance
Melanoma Patient Network EuropeBettina RyllBelgium
Merck KGaA (Ares Trading SA)Charles MassinSwitzerland
MicronitRonny van 't OeverThe Netherlands
Microsoft DenmarkKim IbfeltDenmark
Mila - Quebec Articifcial Intelligence InstituteValérie PisaneCanada
Military Hospital BrusselsVanhoutteBelgium
MinacNedRonny van ‘t OeverThe Netherlands
Mobile Health UnitValerie StormsBelgium
NanobiotixAgnes PottierFrance
National Research Council CanadaJean-François HouleCanada
NC3RsSam JacksonUnited Kingdom
Neurescue Habib Frost, Founder and CEODenmark
Nordic.AILisa MallnerDenmark
NovartisKlaus SeuwenSwitzerland
NXP SemiconductorsRadu SurdeanuThe Netherlands
Ontario GenomicsBettina HamelinCanada
PfizerMark Soued The Netherlands
Philips Electronics Nedeland B.V.Sieger SwavingThe Netherlands
Photonics 21Jürgen Popp, Thomas MayerhoeferGermany
Polytechnique MontréalFrançois BertrandCanada
Praxis PharmaceuticalEusebio GainzaSpain
Praxis Pharmaceutical (Keralty)Eusebio GainzaLatin America
Pryv SA Hubert RidolphiSwitzerland
Robert Bosch GmbHJürgen GrossGermany
Roland Berger GmbHSteffen GackstatterGermany
S.C. Telemedica S.R LMioara RaduRomania
SanofiHartmut RuettenGermany
ServierOlivier NosjeanFrance
SoitecIonut Radu France
ST MicroelectronicsG. Desoli, Rolandi Canegallo, A. Cremonesi, Sabina ConociItaly
Syndicat National de l’Industrie des Technologies Médicales (SNITEM)Florent SurugueFrance
Texas InstrumentsGiovanni FrattiniUnited States
Tissue Click LtdGary Phillips, Anna GuildfordUnited Kingdom
Université de SherbrookeVincent AimezCanada
Vector Institute for Artificial IntelligenceGarth GibsonCanada
VITOBart Van MeerbergenBelgium
Wageningen - Food & Biobased ResearchJurriaan Mes, Liesbeth Luijendijk, Jan Top, Harry WichersThe Netherlands
Wyss Center for Bio and NeuroengineeringTracy LaabsSwitzerland
XsensioEsmeralda MegallySwitzerland
Zilveren Kruis AchmeaAnja MoonenThe Netherlands
© Health EU project - created by SCIPROM

Privacy policy